Jiangsu Lanfeng Bio-chemical Co.,Ltd
Sembol: 002513.SZ
SHZ
4.37
CNYBugünkü piyasa fiyatı
-4.9409
F/K Oranı
0.0015
PEG Oranı
1.49B
MRK Kapağı
- 0.00%
DIV Verimi
Jiangsu Lanfeng Bio-chemical Co.,Ltd (002513-SZ) Finansal Tablolar
Bilanço
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 0 | 457.3 | 24 | 84.6 | |||||||||||||||||
balance-sheet.row.short-term-investments | 0 | 0 | -4.9 | -4.6 | |||||||||||||||||
balance-sheet.row.net-receivables | 0 | 532.3 | 229.2 | 299.2 | |||||||||||||||||
balance-sheet.row.inventory | 0 | 167.8 | 98.1 | 132.7 | |||||||||||||||||
balance-sheet.row.other-current-assets | 0 | 43.5 | 9 | 29.6 | |||||||||||||||||
balance-sheet.row.total-current-assets | 0 | 1575.7 | 360.3 | 546 | |||||||||||||||||
balance-sheet.row.property-plant-equipment-net | 0 | 1526.1 | 868.2 | 935.6 | |||||||||||||||||
balance-sheet.row.goodwill | 0 | 0 | 0 | 0 | |||||||||||||||||
balance-sheet.row.intangible-assets | 0 | 58.6 | 43.6 | 46.9 | |||||||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 0 | 58.6 | 43.6 | 46.9 | |||||||||||||||||
balance-sheet.row.long-term-investments | 0 | 8.9 | 12.3 | 9.5 | |||||||||||||||||
balance-sheet.row.tax-assets | 0 | 126.8 | 96.5 | 170.2 | |||||||||||||||||
balance-sheet.row.other-non-current-assets | 0 | 103.6 | 94.6 | 19.8 | |||||||||||||||||
balance-sheet.row.total-non-current-assets | 0 | 1823.9 | 1115.3 | 1181.9 | |||||||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | |||||||||||||||||
balance-sheet.row.total-assets | 0 | 3399.6 | 1475.5 | 1727.9 | |||||||||||||||||
balance-sheet.row.account-payables | 0 | 1212.9 | 543.2 | 631.7 | |||||||||||||||||
balance-sheet.row.short-term-debt | 0 | 203.3 | 108.3 | 97.3 | |||||||||||||||||
balance-sheet.row.tax-payables | 0 | 22.5 | 4.8 | 1.6 | |||||||||||||||||
balance-sheet.row.long-term-debt-total | 0 | 408.9 | 0.1 | 0.3 | |||||||||||||||||
Deferred Revenue Non Current | 0 | 114.1 | 6.2 | 9 | |||||||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | |||||||||||||||||
balance-sheet.row.other-current-liab | 0 | 185.8 | 333.1 | 8.3 | |||||||||||||||||
balance-sheet.row.total-non-current-liabilities | 0 | 631.5 | 81 | 16.1 | |||||||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | |||||||||||||||||
balance-sheet.row.capital-lease-obligations | 0 | 0.5 | 0.1 | 0.3 | |||||||||||||||||
balance-sheet.row.total-liab | 0 | 3148.9 | 1118 | 1061.3 | |||||||||||||||||
balance-sheet.row.preferred-stock | 0 | 49 | 15.3 | 0 | |||||||||||||||||
balance-sheet.row.common-stock | 0 | 373.9 | 373.9 | 340.1 | |||||||||||||||||
balance-sheet.row.retained-earnings | 0 | -2200 | -1867.7 | -1547 | |||||||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 0 | 5.5 | -15.3 | 74.6 | |||||||||||||||||
balance-sheet.row.other-total-stockholders-equity | 0 | 1796.8 | 1851.4 | 1799 | |||||||||||||||||
balance-sheet.row.total-stockholders-equity | 0 | 25.2 | 357.6 | 666.6 | |||||||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 0 | 3399.6 | 1475.5 | 1727.9 | |||||||||||||||||
balance-sheet.row.minority-interest | 0 | 225.4 | 0 | 0 | |||||||||||||||||
balance-sheet.row.total-equity | 0 | 250.7 | 357.6 | 666.6 | |||||||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 0 | - | - | - | |||||||||||||||||
Total Investments | 0 | 8.9 | 7.4 | 4.9 | |||||||||||||||||
balance-sheet.row.total-debt | 0 | 612.2 | 108.4 | 97.6 | |||||||||||||||||
balance-sheet.row.net-debt | 0 | 154.9 | 84.4 | 13.1 |
Nakit Akış Tablosu
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 0 | -320.7 | -491.2 | 14.8 | ||||||||||||||||
cash-flows.row.depreciation-and-amortization | 0 | 95.8 | 116.4 | 123.9 | ||||||||||||||||
cash-flows.row.deferred-income-tax | 0 | 73.2 | -48.4 | -13.4 | ||||||||||||||||
cash-flows.row.stock-based-compensation | 0 | 9.7 | 48.4 | 13.4 | ||||||||||||||||
cash-flows.row.change-in-working-capital | 0 | 82.3 | 9.6 | 0.6 | ||||||||||||||||
cash-flows.row.account-receivables | 0 | -36.2 | 56.6 | 488.9 | ||||||||||||||||
cash-flows.row.inventory | 0 | 18.7 | -25.5 | 11.1 | ||||||||||||||||
cash-flows.row.account-payables | 0 | 26.6 | 26.8 | -486 | ||||||||||||||||
cash-flows.row.other-working-capital | 0 | 73.2 | -48.4 | -13.4 | ||||||||||||||||
cash-flows.row.other-non-cash-items | 0 | -4.6 | 377 | -11 | ||||||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 0 | 0 | 0 | 0 | ||||||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | 0 | -31.1 | -88.9 | -107.7 | ||||||||||||||||
cash-flows.row.acquisitions-net | 0 | 7.4 | 3.7 | 258.2 | ||||||||||||||||
cash-flows.row.purchases-of-investments | 0 | -37.6 | -10 | 0 | ||||||||||||||||
cash-flows.row.sales-maturities-of-investments | 0 | -7.4 | -3.7 | 0 | ||||||||||||||||
cash-flows.row.other-investing-activites | 0 | 58.9 | 3.7 | 70.2 | ||||||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | 0 | -9.8 | -95.2 | 220.7 | ||||||||||||||||
cash-flows.row.debt-repayment | 0 | -82 | -172.1 | -364.3 | ||||||||||||||||
cash-flows.row.common-stock-issued | 0 | 101.5 | 0 | 0 | ||||||||||||||||
cash-flows.row.common-stock-repurchased | 0 | -101.5 | 0 | 0 | ||||||||||||||||
cash-flows.row.dividends-paid | 0 | -6 | -12.7 | -15.6 | ||||||||||||||||
cash-flows.row.other-financing-activites | 0 | 135.8 | 75.3 | 113.7 | ||||||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 0 | 47.8 | -109.5 | -266.3 | ||||||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | 2.3 | -1 | -6.1 | ||||||||||||||||
cash-flows.row.net-change-in-cash | 0 | -24 | -193.8 | 76.6 | ||||||||||||||||
cash-flows.row.cash-at-end-of-period | 0 | 9 | 33 | 226.8 | ||||||||||||||||
cash-flows.row.cash-at-beginning-of-period | 0 | 33 | 226.8 | 150.2 | ||||||||||||||||
cash-flows.row.operating-cash-flow | 0 | -64.3 | 11.8 | 128.3 | ||||||||||||||||
cash-flows.row.capital-expenditure | 0 | -31.1 | -88.9 | -107.7 | ||||||||||||||||
cash-flows.row.free-cash-flow | 0 | -95.4 | -77.1 | 20.6 |
Gelir Tablosu Satırı
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 0 | 1741.6 | 1445.2 | 1443.9 | |||||||||||||||||
income-statement-row.row.cost-of-revenue | 0 | 1777.3 | 1435.8 | 1448.7 | |||||||||||||||||
income-statement-row.row.gross-profit | 0 | -35.7 | 9.4 | -4.7 | |||||||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | |||||||||||||||||
income-statement-row.row.research-development | 0 | - | - | - | |||||||||||||||||
income-statement-row.row.selling-general-administrative | 0 | - | - | - | |||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||||||||||||||
income-statement-row.row.other-expenses | 0 | -7.7 | 51.8 | 72.3 | |||||||||||||||||
income-statement-row.row.operating-expenses | 0 | 182.3 | 119.3 | 168.7 | |||||||||||||||||
income-statement-row.row.cost-and-expenses | 0 | 1959.6 | 1555.1 | 1617.4 | |||||||||||||||||
income-statement-row.row.interest-income | 0 | 1 | 7.8 | 2.2 | |||||||||||||||||
income-statement-row.row.interest-expense | 0 | 26.5 | 13.6 | 22.6 | |||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||||||||||||||
income-statement-row.row.total-other-income-expensenet | 0 | -136.3 | -137.1 | -7.1 | |||||||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | |||||||||||||||||
income-statement-row.row.other-operating-expenses | 0 | -7.7 | 51.8 | 72.3 | |||||||||||||||||
income-statement-row.row.total-operating-expenses | 0 | -136.3 | -137.1 | -7.1 | |||||||||||||||||
income-statement-row.row.interest-expense | 0 | 26.5 | 13.6 | 22.6 | |||||||||||||||||
income-statement-row.row.depreciation-and-amortization | 0 | 98.2 | 38.4 | 463.3 | |||||||||||||||||
income-statement-row.row.ebitda-caps | 0 | - | - | - | |||||||||||||||||
income-statement-row.row.operating-income | 0 | -346.7 | -109.9 | -531.8 | |||||||||||||||||
income-statement-row.row.income-before-tax | 0 | -354.3 | -247 | -538.9 | |||||||||||||||||
income-statement-row.row.income-tax-expense | 0 | -6.6 | 73.7 | -47.7 | |||||||||||||||||
income-statement-row.row.net-income | 0 | -332.3 | -320.7 | -491.2 |
Sıkça Sorulan Sorular
Nedir Jiangsu Lanfeng Bio-chemical Co.,Ltd (002513.SZ) toplam varlıklar?
Jiangsu Lanfeng Bio-chemical Co.,Ltd (002513.SZ) toplam varlıklar 3399589930.000 şeklindedir.
İşletmenin yıllık geliri nedir?
Yıllık gelir N/A'dur.
Firma kâr marjı nedir?
Firma kar marjı -0.026'dir.
Şirket serbest nakit akışı nedir?
Serbest nakit akışı -2.516'dur.
İşletme net kar marjı nedir?
Net kâr marjı -0.200'dir.
Firma toplam geliri nedir?
Toplam gelir -0.221'dur.
Nedir Jiangsu Lanfeng Bio-chemical Co.,Ltd (002513.SZ) net kar (net gelir)?
Net kar (net gelir) -332260445.980'dur.
Firmanın toplam borcu nedir?
Toplam borç 612238812.000'dir.
Faaliyet giderleri rakamı nedir?
İşletme giderleri 182291568.000'dır.
Şirket nakit rakamı nedir?
İşletme içi nakit 0.000'tir.